Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …

Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological
wound healing response and can occur in various organs such as the heart, lung, liver …

Pulmonary fibrosis (PF) encompasses a spectrum of chronic lung diseases that
progressively impact the interstitium, resulting in compromised gas exchange …

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comprises group of
small vessel vasculitides, including granulomatosis with polyangiitis (GPA), microscopic …

Pulmonary fibrosis (PF) is a chronic interstitial lung disorder characterized by abnormal
myofibroblast activation, accumulation of extracellular matrix (ECM), and thickening of …

Ethnopharmacological relevance Interstitial lung disease (ILD) is a chronic lung dysfunction
disease with a poor prognosis and poor recovery. The clinically used therapeutic drugs …

O‐GlcNAcylation functions as a cellular nutrient and stress sensor and participates in almost
all cellular processes. However, it remains unclear whether O‐GlcNAcylation plays a role in …

Pulmonary fibrosis is a debilitating and life-limiting lung condition in which the damage-
response mechanisms of mixed-population cells within the lungs go awry. The tissue …

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a collection of
systemic autoimmune disorders resulting in lung interstitial abnormalities or lung fibrosis …

In recent years, the role of ferroptosis in pulmonary fibrosis has garnered increasing interest
as a potential therapeutic target. Pulmonary fibrosis is a pathological process characterized …